Cost-effectiveness of Nonmelanoma Skin Cancer Screening in Crohnʼs Disease Patients

• DOI: 10.1097/01.mib.0000435850.17263.13
• Publication Date: 2013-11-05T07:38:23Z
• Authors: Philip N. Okafor; Christopher G. St...; Linda Nguyen; Debjani Sahni; Sharmeel K. Wasan; Francis A. Farraye; Daniel O. Erim
• Keywords: Adult; Male; Skin Neoplasms; Cost-Benefit Analysis; Middle Aged; Models, Theoretical; Prognosis; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Crohn Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Female; Quality-Adjusted Life Years; Early Detection of Cancer; Follow-Up Studies

BackgroundSeveral studies have demonstrated an increased risk of nonmelanoma skin cancer (NMSC) in patients with inflammatory bowel disease, the greatest Crohn's disease (CD). We investigated cost-effectiveness NMSC screening CD.